Common-Size Balance Sheet: Assets
Quarterly Data
Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Analysis of Liquidity Ratios
- Enterprise Value (EV)
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Current Ratio since 2005
- Price to Earnings (P/E) since 2005
- Price to Book Value (P/BV) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Vertex Pharmaceuticals Inc., common-size consolidated balance sheet: assets (quarterly data)
Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Cash and Cash Equivalents
- Cash and cash equivalents as a percentage of total assets showed a generally declining trend starting from a high of over 50% between late 2020 and early 2023, decreasing significantly to around 20% by early 2025. This suggests a reduction in highly liquid assets relative to total assets over time, possibly reflecting greater investment in other asset classes or increased operating activities.
- Marketable Securities
- Marketable securities exhibited moderate fluctuation, maintaining a low percentage generally between 3% and 7% of total assets. A notable dip to around 1.5% occurred at the end of 2022, followed by recovery to about 6-7% in 2024, indicating periods of disinvestment and reinvestment in short-term securities.
- Accounts Receivable, Net
- The accounts receivable proportion remains relatively stable, fluctuating mostly between 7% and 9%, with a slight decline in recent quarters. This stability indicates consistent revenue recognition and collection practices.
- Inventories
- Inventories steadily increased from approximately 2.1% of total assets in early 2020 to over 6% by early 2025. This upward trend suggests a buildup of stock, possibly in anticipation of higher sales, increased production, or a strategic decision to hold more inventory.
- Prepaid Expenses and Other Current Assets
- These assets show variability, with spikes peaking above 4% in the middle of 2021 and again in late 2022, but generally hovering around 2% to 3%. This inconsistency may reflect timing differences in prepaid expenses or changes in other short-term asset management.
- Current Assets
- The proportion of current assets to total assets increased up to about 73% by late 2022, then decreased steadily to approximately 43% in early 2025. This reflects a shift from current to long-term assets beginning in 2023, indicating potential asset reallocation toward longer duration holdings.
- Property and Equipment, Net
- Property and equipment values as a share of total assets decreased from around 8% to just above 5% during the period, suggesting either depreciation, asset disposals, or slower reinvestment in fixed assets relative to overall asset growth.
- Goodwill
- Goodwill decreased consistently from over 11% in early 2020 to below 5% by early 2025. This decline indicates possible impairments, disposals, or fewer acquisitions generating goodwill, reflecting changes in acquisition strategy or asset revaluation.
- Other Intangible Assets, Net
- This category fluctuated around 2% to 4%, with some notable variation such as increases around mid-2023 and declines toward mid-2025, indicating varying amortization or possible write-downs in intangible assets.
- Deferred Tax Assets
- Deferred tax assets remained relatively stable between roughly 6% and 12% of total assets, with a slight increase noticeable toward the later periods suggesting adjustments in tax-related asset recognition.
- Operating Lease Assets
- Operating lease assets showed a declining trend from around 2.7% in 2020 to below 1.3% by 2023, followed by a sharp increase peaking near 6% in late 2024 before slightly declining again, indicating fluctuations in lease-related asset recognition possibly due to changing lease commitments.
- Long-Term Marketable Securities
- Long-term marketable securities started nearly absent, then increased significantly from late 2022 onward, reaching nearly 23.5% by mid-2025. This sharp increase highlights a strategic shift toward longer-term investment holdings over recent quarters.
- Other Assets
- Other assets remained a small portion of total assets, generally under 5%, but with a gradual increase over time, indicating minor growth in miscellaneous long-term or noncurrent assets.
- Long-Term Assets
- The share of long-term assets decreased initially from nearly 39% in early 2020 to below 27% by late 2021, then reversed course with a steady increase to over 56% by mid-2025. This indicates a significant reallocation of capital from current into long-term assets in recent years, potentially reflecting an emphasis on longer-term growth or investment strategies.
- Total Assets
- Total assets are consistently represented as 100%, serving as the base for all percentage calculations within the available data.